The explanation is on the March investor call . The fda has info from 2 complete trials and it’s up to them to tell Cytodyn which one they want the company to submit further data on . Which can be obtained in 3-5 days . I don’t know if the fda has or not . If they haven’t then the it’s the companies fault for not happening yet . If fda has not told the company which one to move forward with then it’s on them . Everyone here should listen to the conference on company website from mar 3?.Its an hour so make time